Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 280976)

Published in Infect Immun on August 01, 1993

Authors

P H Nibbering1, O Pos, A Stevenhagen, R Van Furth

Author Affiliations

1: Department of Infectious Diseases, University Hospital, Leiden, The Netherlands.

Articles citing this

Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19

Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium? Front Microbiol (2011) 1.04

Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol (1998) 1.03

Transcriptional analysis of Mycobacterium fortuitum cultures upon hydrogen peroxide treatment using the novel standard rrnA-P1. BMC Microbiol (2008) 0.85

'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med (2016) 0.82

Analysis of the precursor rRNA fractions of rapidly growing mycobacteria: quantification by methods that include the use of a promoter (rrnA P1) as a novel standard. J Bacteriol (2005) 0.81

Mycobacterium bovis bacilli Calmette-Guerin regulates leukocyte recruitment by modulating alveolar inflammatory responses. Innate Immun (2011) 0.81

Differential macrophage response to slow- and fast-growing pathogenic mycobacteria. Biomed Res Int (2014) 0.80

Induction of interleukin-8 production via nuclear factor-kappaB activation in human intestinal epithelial cells infected with Vibrio vulnificus. Immunology (2005) 0.78

Mycobacterium tuberculosis-triggered Hippo pathway orchestrates CXCL1/2 expression to modulate host immune responses. Sci Rep (2016) 0.77

Elevated CXCL-8 expression in bronchoalveolar lavage correlates with disease severity in patients with acute respiratory distress syndrome resulting from tuberculosis. J Inflamm (Lond) (2014) 0.76

Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils. PLoS One (2016) 0.75

Articles cited by this

Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1991) 8.98

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med (1991) 8.70

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med (1988) 7.12

The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science (1989) 6.89

Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev (1992) 5.11

Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science (1989) 4.99

A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med (1988) 4.86

Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology (1986) 3.33

Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med (1991) 2.96

Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis (1987) 2.93

Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J (1988) 2.83

Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis (1990) 2.66

Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J Gen Microbiol (1978) 2.58

Capacity of human neutrophils to kill Mycobacterium tuberculosis. J Infect Dis (1987) 2.43

Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med (1990) 2.42

Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J Clin Invest (1979) 2.42

Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology (1989) 2.31

Interleukin-8 induces neutrophil transendothelial migration. Immunology (1991) 2.01

Antimicrobial polypeptides of human neutrophils. Blood (1990) 1.98

Assay of H2O2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J Immunol Methods (1983) 1.85

Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J Immunol Methods (1991) 1.83

Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol (1990) 1.78

Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74

Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol (1990) 1.65

Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur J Immunol (1980) 1.55

The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils. Biochem J (1988) 1.49

Interleukin-8 induces changes in human neutrophil actin conformation and distribution: relationship to inhibition of adhesion to cytokine-activated endothelium. J Leukoc Biol (1992) 1.39

Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol (1989) 1.36

Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1. J Leukoc Biol (1990) 1.33

Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol (1991) 1.26

Human neutrophils, activated with cytokines or not, do not kill virulent Mycobacterium tuberculosis. J Infect Dis (1991) 1.26

Interferon-gamma-activated human granulocytes kill ingested Mycobacterium fortuitum more efficiently than normal granulocytes. Eur J Immunol (1990) 1.24

Staurosporine inhibits the respiratory burst and induces exocytosis in human neutrophils. Biochem J (1989) 1.16

Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1). Cytokines (1992) 1.10

Virulence of Mycobacterium tuberculosis and susceptibility to peroxidative killing systems. J Gen Microbiol (1978) 1.01

Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. Am J Med (1987) 0.93

NAP-1/IL-8 induces up-regulation of CR1 receptors in human neutrophil leukocytes. Biochem Biophys Res Commun (1990) 0.90

Articles by these authors

Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J Exp Med (1973) 2.94

IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol (1992) 2.73

Mean cell volume of human blood leucocytes and resident and activated murine macrophages. J Immunol Methods (1990) 1.48

The effects of immunization in human immunodeficiency virus type 1 infection. N Engl J Med (1996) 1.38

Functions of phagocytic cells in chronic mucocutaneous candidiasis. Br Med J (1978) 1.37

Effects of monocytopenia and anticoagulation in experimental Streptococcus sanguis endocarditis. Br J Exp Pathol (1980) 1.36

Interferon-gamma-activated human granulocytes kill ingested Mycobacterium fortuitum more efficiently than normal granulocytes. Eur J Immunol (1990) 1.24

Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages. Immunology (1987) 1.21

Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intra-alveolar administration of aerosolized heat-killed BCG. Am Rev Respir Dis (1983) 1.20

In vitro synthesis of the foetal alpha 1-globulin in man. Nature (1969) 1.16

Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages. J Antimicrob Chemother (1990) 1.13

Estimation of the membrane potential of cultured macrophages from the fast potential transient upon microelectrode entry. J Cell Biol (1983) 1.04

Method to select mice in the steady state for biological studies. J Immunol Methods (1985) 1.03

Impaired phagocytosis of Staphylococcus aureus by granulocytes and monocytes of AIDS patients. Clin Exp Immunol (1992) 1.02

Synthesis of immunoglobulin and secretory component by gastrointestinal mucosa in patients with hypogammaglobulinaemia or IgA deficiency. Clin Exp Immunol (1976) 0.99

Glycosylation of three molecular forms of human alpha 1-acid glycoprotein having different interactions with concanavalin A. Variations in the occurrence of di-, tri-, and tetraantennary glycans and the degree of sialylation. Eur J Biochem (1988) 0.97

Characterization of the adherence of human monocytes to cytokine-stimulated human macrovascular endothelial cells. Immunology (1991) 0.94

A micromethod for the separate evaluation of phagocytosis and intracellular killing of Staphylococcus aureus by human monocytes and granulocytes. J Immunol Methods (1983) 0.94

Nitrite production by activated murine macrophages correlates with their toxoplasmastatic activity, Ia antigen expression, and production of H2O2. Immunobiology (1991) 0.94

Determination of blood volume in the mouse with 51chromium-labelled erythrocytes. J Immunol Methods (1984) 0.93

Effects of monomethylfumarate on human granulocytes. J Invest Dermatol (1993) 0.92

Interaction of povidone-iodine compounds, phagocytic cells, and microorganisms. Antimicrob Agents Chemother (1982) 0.91

Immunocytochemical analysis of cellular responses to BCG. Clin Exp Immunol (1989) 0.90

The formation of immunoglobulins by circulating lymphocytes. Semin Hematol (1969) 0.90

[Reactive and paraprotein gamma-macroglobulins in human serum and cerebrospinal fluid]. Ann Inst Pasteur (Paris) (1967) 0.89

Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production. Parasite Immunol (2001) 0.88

In vitro studies in nickel allergy: diagnostic value of a dual parameter analysis. J Invest Dermatol (1987) 0.87

Micro-CO2-incubator for use on a microscope. J Immunol Methods (1983) 0.86

Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2. AIDS (1995) 0.85

Effect of IFN-gamma on the proliferation of Toxoplasma gondii in monocytes and monocyte-derived macrophages from AIDS patients. Immunology (1994) 0.85

Restoration of the toxoplasmastatic activity of monocytes from AIDS patients during in vivo treatment with interferon-gamma. J Infect Dis (1993) 0.84

A cell-ELISA for the quantification of adherent murine macrophages and the surface expression of antigens. J Immunol Methods (1990) 0.84

The flora of renal haemodialysis shunt sites. J Clin Pathol (1975) 0.84

Macrophages in bronchoalveolar lavage fluid are not representative of macrophages in granulomas of the lungs of BCG-infected mice. J Pathol (1989) 0.83

Deficient intracellular killing of bacteria by murine alveolar macrophages. Am J Respir Cell Mol Biol (1989) 0.82

Cross-reactivity among birch pollen, vegetables and fruits as detected by IgE antibodies is due to at least three distinct cross-reactive structures. Allergy (1987) 0.82

Characterization of mononuclear phagocytes from the mouse, guinea pig, rat, and man. Inflammation (1982) 0.81

Expression of zeta molecules is decreased in NK cells from HIV-infected patients. FEMS Immunol Med Microbiol (1999) 0.80

A cytophotometric method to quantitate the binding of monoclonal antibodies to individual cells. J Histochem Cytochem (1985) 0.80

S. typhi vaccine strain Ty21a can cause a generalized infection in whole body-irradiated but not in hydrocortisone-treated mice. Scand J Immunol (1995) 0.79

[Presence and synthesis of immunoglobulins in tissues of the gastro-intestinal and respiratory tracts, in the conjuctival and vaginal mucosa and in the skin]. Prog Immunobiol Stand (1970) 0.78

Monocytes incubated with surfactant: a model for human alveolar macrophages? J Leukoc Biol (1997) 0.78

Review of the origin and kinetics of the promonocytes, monocytes, and macrophages and a brief discussion of the mononuclear phagocyte system. Ann Inst Pasteur (Paris) (1971) 0.77

Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces toxoplasmastatic activity of human monocytes via induction of prostaglandin E2 (PGE2). Clin Exp Immunol (1995) 0.77

Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice. Biochem J (1991) 0.77

Reduced toxoplasmastatic activity of monocytes from AIDS patients: a role for granulocyte-macrophage colony-stimulating factor. Scand J Immunol (1998) 0.76

Arachidonic acid, but not its metabolites, is essential for FcgammaR-stimulated intracellular killing of Staphylococcus aureus by human monocytes. Immunology (1999) 0.75

Endemic infection in surgical wards. J Hyg (Lond) (1975) 0.75

Increased activity of FIM in serum of mice during a Mycobacterium bovis (BCG) infection. Immunology (1990) 0.75

Antimicrobial factors in the exudates of skin windows in human subjects. Clin Exp Immunol (1976) 0.75

Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough. Scand J Immunol (2000) 0.75

Characterization of the efficiency of a cell separation process by the extent of elimination of a contaminating cell type. Anal Biochem (1990) 0.75

Intracellular signalling by binding sites for the antipsoriatic agent monomethylfumarate on human granulocytes. Br J Dermatol (1997) 0.75

A reaction vessel for the measurement of oxygen consumption by small numbers of cells in suspension. J Immunol Methods (1986) 0.75

The effect of hydrocortisone acetate and azathioprine (Imuran) on the kinetics of neutrophilic polymorphonuclear leucocytes during an acute inflammation. Proc Soc Exp Biol Med (1977) 0.75

Monocyte adherence to human vascular endothelium. Behring Inst Mitt (1993) 0.75

Proceedings: In-vitro synthesis of immunoglobulins, secretory component, and lysozyme by normal and pathological human gastro-intestinal mucosa. Gut (1975) 0.75

Immunoglobulin synthesis in man during ontogeny. Minerva Pediatr (1971) 0.75

Functions of peripheral-blood monocytes and granulocytes in cutaneous T-cell lymphoma. Br J Dermatol (1982) 0.75

Efficacy of cloxacillin prophylaxis in craniotomy: a one year follow-up study. Scand J Infect Dis (1991) 0.75